Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Herbal Treatment of Hepatitis C in Methadone Maintained Patients Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Herbal Treatment of Hepatitis C in Methadone Maintained Patients conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Herbal Treatment of Hepatitis C in Methadone Maintained Patients Clinical research trials and Herbal Treatment of Hepatitis C in Methadone Maintained Patients healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Herbal Treatment of Hepatitis C in Methadone Maintained Patients. Herbal Treatment of Hepatitis C in Methadone Maintained Patients Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Herbal Treatment of Hepatitis C in Methadone Maintained Patients clinical trial. Subjects frequently obtain the most expert healthcare possible for their Herbal Treatment of Hepatitis C in Methadone Maintained Patients condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "H" Clinical Trials Conditions > Herbal Treatment of Hepatitis C in Methadone Maintained Patients

Herbal Treatment of Hepatitis C in Methadone Maintained Patients



Herbal Treatment of Hepatitis C in Methadone Maintained Patients

For Condition: Hepatitis C
Status: No longer recruiting
Sponsor(s): National Center for Complementary and Alternative Medicine (NCCAM) ,
Synopsis: Hepatitis C (HCV) is a chronic viral illness leading to progressive liver damage that has emerged as a major public health issue in the United States. While HCV affects all population groups, individuals with a history of intravenous drug use form the largest known risk group. Between 90 and 100 percent of long term intravenous drug use will eventually test positive for HCV, and there is substantial risk that even short term experimentation will result in infection. Studies suggest that HCV will be the major cause of cirrhosis and liver cancer in the next century. Currently, approved therapy includes recombinant interferons, which lead to sustained remission in a minority of patients. However, patients abusing other substances, including alcohol, are not eligible for interferon therapy. The need for investigation into other potential therapies is clear. Current practice patterns in the Far East include the use of traditional herbal remedies for symptomatic chronic viral hepatitis. This study is intended to examine the effect of commonly used herbal remedies for the treatment of symptomatic HCV.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control
Minimum Age/Maximum Age: 18 Years/70 Years
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - English speaking/reading - Serum positive for HCV virus by PCR - Elevated alanine transferase (ALT) within 6 months of the Entry Visit, unattributable to causes other than HCV - Liver biopsy within 2 years of entry confirming that the histological diagnosis is consistent with chronic HCV - Laboratory parameters available at the Entry Visit including CBC, differential, and platelet count.
Total Enrollment: 

Location and Contact Information:

Overall Study Official:
JeffAlbrecht,  Principal Investigator,  Hennepin County Medical Center - Minneapolis

Hennepin County Medical Center
Minneapolis,  Minnesota, 
United States
 


Additional Information:
Study ID Numbers:
  8 P50 AT00009-02P3;  5 P50 AT00009-03,8 P50 AT00009-02
Study Start Date: 
Record last reviewed: April 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00010816

Other Hepatitis C Studies:
1. Treatment of Cholestatic Pruritus With Sertraline

2. History of Hepatitis C in Volunteer Blood Donors

3. Immune Response to Hepatitis C Virus

4. The Impact of HAART on Response to Hepatitis C Treatment in Patients Taking Peginterferon alpha-2b and Ribavirin

5. Hepatitis C Antiviral Resistance in African-Americans

Related Studies:

Other Hepatitis C Clinical Trials
Other Minnesota Clinical Trials
Other Minneapolis Clinical Trials

Herbal Treatment of Hepatitis C in Methadone Maintained Patients

Modify your Search

  Other Hepatitis C Clinical Trials
  Other Minnesota Clinical Trials
  Other Minneapolis Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103